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nfections with 
 
Staphylococcus aureus
 
, a common inducer
of septic and toxic shock, often result in tissue damage
and death of various cell types. Although 
 
S. aureus
 
 was
suggested to induce apoptosis, the underlying signal
transduction pathways remained elusive. We show that
caspase activation and DNA fragmentation were induced
 
not only when Jurkat T cells were infected with intact
 
bacteria, but also after treatment with supernatants of various
 
S. aureus
 
 strains. We also demonstrate that 
 
S. aureus
 
–induced
cell death and caspase activation were mediated by 
 
 
 
-toxin,
 
a major cytotoxin of 
 
S. aureus
 
, since both events were
abrogated by two different anti–
 
 
 
-toxin antibodies and
 
could not be induced with supernatants of an 
 
 
 
-toxin–
I
 
deﬁcient 
 
S. aureus
 
 strain. Furthermore, 
 
 
 
-toxin–induced
caspase activation in CD95-resistant Jurkat sublines lacking
CD95, Fas-activated death domain, or caspase-8 but not in
cells stably expressing the antiapoptotic protein Bcl-2.
Together with our ﬁnding that 
 
 
 
-toxin induces cytochrome
c release in intact cells and, interestingly, also from isolated
mitochondria in a Bcl-2-controlled manner, our results
 
demonstrate that 
 
S. aureus
 
 
 
 
 
-toxin triggers caspase activation
via the intrinsic death pathway independently of death
receptors. Hence, our ﬁndings clearly deﬁne a signaling
pathway used in 
 
S. aureus
 
–induced cytotoxicity and may
provide a molecular rationale for future therapeutic inter-
ventions in bacterial infections.
 
Introduction
 
Apoptosis, or programmed cell death, is a genetically well-
defined intrinsic suicide program that enables an organism to
remove mutated or infected cells without causing an inflamma-
tory reaction. Cells undergoing apoptosis show a characteristic
sequence of morphological and biochemical features including
membrane blebbing, cellular shrinkage, and condensation of
chromatin. Recent studies demonstrate that these key morpho-
logical alterations of apoptosis are mediated essentially by a
family of intracellular cysteine proteases called caspases
(Cohen, 1997; Cryns and Yuan, 1998; Los et al., 1999).
Caspases are synthesized as inactive proenzymes and pro-
teolytically processed to form an active complex composed
of two heterodimeric subunits of 
 
 
 
10 and 20 kD. Based on
their structure and order in cell death pathways, caspases can
be divided into initiator and effector caspases. Initiator
caspases, such as caspase-8 or -9, exert regulatory roles.
Upon binding to signal transducing molecules, they activate
downstream effector caspases such as caspase-3, -6, or -7,
which finally cleave various cellular substrates, thereby in-
ducing the demise of the cell (Cryns and Yuan, 1998; Stroh
and Schulze-Osthoff, 1998; Porter and Jänicke, 1999).
Activation of caspases is achieved via two principal signal-
ing pathways, namely the extrinsic and intrinsic death path-
ways (for review see Schulze-Osthoff et al., 1998; Li and
Yuan, 1999). The extrinsic death pathway involves the liga-
tion of death receptors (CD95/Fas/APO-1; TNF receptor-1)
that leads to the recruitment of the adapter molecule Fas-
activated death domain (FADD)* and pro–caspase-8 into a
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death-inducing signaling complex. The intrinsic death path-
way is initiated at the mitochondrion by the release of cyto-
chrome c, a process that can be inhibited by antiapoptotic
proteins of the Bcl-2 family. When released, cytosolic cyto-
chrome c binds together with dATP and the apoptosis-acti-
vating factor-1 to pro–caspase-9 to form the apoptosome.
Upon formation of the death-inducing signaling complex or
the apoptosome, pro–caspase-8 or -9, respectively, are auto-
proteolytically processed, resulting in the activation of
downstream caspases.
Numerous death stimuli can trigger apoptosis, and even
several species of microbial pathogens were shown in recent
years to activate and modulate components of the cellular
death machinery (Gao and Kwaik, 2000). Amongst these
belongs 
 
Staphylococcus aureus
 
, one of the most common
gram-positive bacterial pathogens in humans that plays an
increasing role in nosocomial infections (Lowy, 1998).
Breached mucocutaneous membranes or impaired host im-
munity facilitate tissue invasion and bloodstream dissemina-
tion of 
 
S. aureus
 
. This is followed by serious infections, such
as abscess formation, osteomyelitis, endocarditis, or pneu-
monia, which often require a prolonged and aggressive anti-
biotic treatment. Among the most serious complications of
 
S. aureus
 
 infections are manifestations of septic and toxic
shock syndromes that may lead to multiple organ failure
(Marrack and Kappler, 1990).
Since tissue injury and a depletion of immune cells, in-
cluding macrophages and T cells, are characteristic features
of septic and toxic shock syndromes, several studies in the
past decade have focused on cell death induction after expo-
sure to microbial pathogens (for review see Weinrauch and
Zychlinsky, 1999; Gao and Kwaik, 2000). In contrast to its
original function to eliminate cells without causing an in-
flammatory reaction, there is growing evidence that apop-
totic tissue damage or immune suppression may contribute
significantly to the risk of secondary opportunistic infections
(Oberholzer et al., 2001). A paradigm of bacteria-induced
apoptosis is the infection of macrophages with 
 
Shigella flex-
neri
 
, which involves the activation of caspase-1 and release of
IL-1
 
 
 
, resulting in an acute inflammatory response (Zych-
linsky et al., 1992). On the other hand, 
 
Yersinia enterocolit-
ica
 
 translocates soluble proteins belonging to the Yop family
in the host that can inhibit the activation of the antiapop-
totic transcription factor NF-
 
 
 
B (Ruckdeschel et al., 1998).
It has also been shown that some bacteria such as 
 
Pseudomo-
nas aeruginosa
 
 or 
 
Helicobacter pylori
 
 utilize the CD95 death
receptor/ligand system to induce apoptosis in infected target
cells (Rudi et al., 1998; Grassme et al., 2000). Nevertheless,
although pathogens possess a plethora of strategies to control
the fate of the host cell, in most cases the underlying mecha-
nisms of bacteria-induced cell death remain unclear.
In the present study, we investigated the mechanism of
cell death in T cells after 
 
S. aureus
 
 infection. We show that
not only in Jurkat T-lymphocytes but also in human periph-
eral blood lymphocytes (PBLs) and monocytes 
 
S. aureus
 
–
induced cytotoxicity can be mediated by 
 
 
 
-toxin, a soluble
pore-forming toxin, and does not require bacterial internal-
ization. We further demonstrate that 
 
 
 
-toxin–induced cyto-
toxicity and caspase activation do neither involve CD95 nor
other death receptors but instead the activation of the mito-
chondrial apoptosis machinery. Interestingly, 
 
 
 
-toxin was
able to induce the proapoptotic release of cytochrome c not
only from intact cells but also from isolated mitochondria.
Therefore, our results clearly define a signaling pathway of 
 
S.
aureus
 
–induced cell death and indicate that besides pore for-
mation in the plasma membrane, 
 
S. aureus
 
 
 
 
 
-toxin utilizes a
direct mechanism to trigger cell death in target cells.
 
Results
 
A soluble factor in supernatants of 
 
S. aureus
 
 cultures is 
sufficient for cell death induction
 
To assess the cytotoxic potential of different 
 
S. aureus
 
 strains
and investigate whether intact bacteria are required for this
process, Jurkat leukemic T cells were incubated with various
cytotoxic or noncytotoxic 
 
S. aureus
 
 strains or with their re-
spective culture supernatants. As measured by the formation
of hypodiploid DNA, both washed whole bacteria (Fig. 1 A)
of the cytotoxic and hemolytic 
 
S. aureus
 
 strains 6850 and
RN6390 and their respective supernatants (Fig. 1 B) effi-
ciently induced apoptosis of Jurkat cells in a dose- and time-
dependent manner. Remarkably, cell death induction by ei-
ther supernatants or intact bacteria was achieved to a similar
extent and with similar kinetics as with an agonistic anti-
CD95 antibody. In contrast, the noncytotoxic and non-
hemolytic 
 
S. aureus
 
 strain Cowan I and the nonpathogenic
 
S. carnosus
 
 strain TM300 did not induce cell death.
 
 
 
-Toxin is a mediator of 
 
S. aureus
 
–induced cell death
 
We next investigated the nature of the soluble factor in 
 
S.
aureus
 
 culture supernatants, which was responsible for cell
death induction. Interestingly, in Coomassie-stained SDS-
polyacrylamide gels, we observed a remarkable correlation
between the expression levels of 
 
 
 
-toxin, the major cytolysin
of 
 
S. aureus
 
, and the cytotoxic potential of the various 
 
S. au-
Figure 1. Both intact S. aureus cells and bacterial supernatants 
induce T cell apoptosis. Jurkat cells were incubated with live 
washed bacteria (A) or sterile-filtered supernatants of the same 
bacterial cultures (B). After the indicated times, the proportion of 
apoptotic cells was determined by flow cytometry. (A) Fresh suspen-
sions of the indicated bacterial strains were added to Jurkat cells, 
resulting in a MOI of 30 (low) and 120 (high). Cells were incubated 
on ice for 2 h to allow sedimentation and then shifted to 37 C. Lyso-
staphin (20  g/ml) was added to lyse and kill staphylococci. Lyso-
staphin without bacteria served as a negative control, whereas 
agonistic anti-CD95 was used as a positive control. (B) Fresh 
bacterial supernatants were added to Jurkat cells, resulting in a final 
concentration (vol/vol) of 0.1% (low) and 1% (high). 
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reus
 
 strains (unpublished data). 
 
S. aureus
 
 
 
 
 
-toxin has been
reported to damage cells by the generation of pores in the
plasma membrane (Jonas et al., 1994); however, its precise
role in apoptotic pathways has not been established yet. To
analyse the cytotoxic potential of this molecule in more de-
tail, Jurkat T cells were incubated with various concentra-
tions of a commercially available 
 
 
 
-toxin in the absence or
presence of an 
 
 
 
-toxin neutralizing antibody. As shown in
Fig. 2 A, 
 
 
 
67% of Jurkat cells were apoptotic after treat-
ment with 
 
 
 
-toxin concentrations ranging from 0.1 to 10
 
 
 
g/ml. The addition of the 
 
 
 
-toxin neutralizing antibody
resulted in a dose-dependent inhibition of cell death
achieved with 0.1 or 1 
 
 
 
g/ml 
 
 
 
-toxin. In contrast, the anti-
body could not inhibit cell death when 10 
 
 
 
g/ml 
 
 
 
-toxin
were used (Fig. 2 A) or when apoptosis was induced with
anti-CD95 (unpublished data), demonstrating the specific-
ity of the 
 
 
 
-toxin antibody. More interestingly, when Jurkat
cells were treated with supernatants of the moderately and
highly cytotoxic 
 
S. aureus
 
 strains RN6390 (Fig. 2 B) and
Wood 46 (Fig. 2 C), respectively, apoptosis could be inhib-
ited completely with two different neutralizing 
 
 
 
-toxin anti-
bodies. Normal rabbit serum that was used as a control had
no effect. To further verify this finding, we incubated Jurkat
cells with supernatants of the 
 
 
 
-toxin–producing but FnBP-
deficient and thus noninvasive 
 
S. aureus
 
 strain DU5883 and
DU1090, an 
 
 
 
-toxin knock-out mutant. Only the superna-
tant of the 
 
 
 
-toxin–producing strain DU5883 was able to
induce the dose-dependent death of Jurkat cells, whereas the
supernatant of the 
 
 
 
-toxin knock-out strain DU1090 had
no effect (Fig. 2 D).
SDS-polyacrylamide electrophoresis revealed minor im-
purities of the commercially available 
 
 
 
-toxin preparation
(Fig. 2 E, lane 3). To exclude that these contaminants con-
tributed to the observed cell death induction, we compared
the cytotoxic effect of this preparation with highly purified
 
 
 
-toxin (Palmer et al., 1993), which is characterized as a sin-
gle band with the expected molecular weight of 34 kD (Fig.
2 E, lane 2). As both 
 
 
 
-toxin preparations efficiently in-
duced death of Jurkat cells with a similar dose dependency
(Fig. 2 F), our data clearly demonstrate that 
 
 
 
-toxin is a sol-
uble mediator of 
 
S. aureus
 
–induced cell death.
 
 
 
-Toxin is required for 
 
S. aureus
 
–induced 
caspase-3 activation
 
Apoptosis is mediated essentially by activation of the caspase
cascade, resulting in cleavage of several death substrates. To
examine the cell death pathway induced by 
 
S. aureus
 
 and es-
pecially by 
 
 
 
-toxin in more detail, we incubated Jurkat cells
with supernatants of the various 
 
S. aureus
 
 strains and ana-
lyzed the cell extracts for caspase-3 activity as determined by
their ability to cleave the fluorogenic substrate 
 
N
 
-acetyl-Asp-
Glu-Val-Asp-aminomethyl-coumarin (DEVD-AMC). Su-
pernatants of the 
 
S. aureus
 
 strains Wood 46, RN6390, 6850,
and DU5883 significantly induced caspase-3 activity in a
dose-dependent manner, whereas no DEVD-AMC cleavage
activity could be detected in untreated Jurkat cells or in cells
incubated with supernatants of the nontoxic 
 
S. carnosus
 
strain TM300 (Fig. 3 A). DEVDase activity was first de-
tected 75 min after stimulation and reached a plateau at 
 
 
 
3 h
(unpublished data). Interestingly, the supernatants of the
cytotoxic 
 
S. aureus
 
 strains induced a sharp increase in cas-
pase-3 activity which, however, declined rapidly after an in-
dividual peak was reached. It is also noteworthy that the ex-
tent of caspase-3 activation correlated directly with the
cytotoxic potential of the various S. aureus strains and was
most pronounced with supernatants of Wood 46 and
RN6390 (Fig. 2, B and C, compared with Fig. 3 A).
To demonstrate that S. aureus–induced caspase-3 activa-
tion was mediated by  -toxin, we also measured DEVD-
AMC cleavage activity in cell extracts of Jurkat cells treated
with  -toxin or with Wood 46 supernatant in the presence
of the neutralizing anti– -toxin antibody. As expected, the
Figure 2. S. aureus  -toxin is required for induction of apoptosis. 
(A) Effect of purified  -toxin. Jurkat cells were preincubated for 30 
min with various dilutions of a sheep anti– -toxin antiserum and 
then incubated with the indicated concentrations of the commer-
cially available preparation of  -toxin. (B and C) Anti– -toxin 
neutralizes the proapoptotic activity of S. aureus supernatants. 
Jurkat cells were preincubated with various dilutions of a sheep 
anti– -toxin antiserum, a rabbit anti– -toxin antiserum, or normal 
rabbit serum (NRS) for 30 min. Subsequently, sterile-filtered super-
natants of RN6390 (B) or Wood 46 (C) were added at the indicated 
dilutions, and formation of hypodiploid nuclei was assessed. (D) 
 -Toxin–deficient S. aureus does not induce apoptosis. Jurkat cells 
were incubated with various concentrations of supernatants of the 
 -toxin–producing strain DU5883 or its  -toxin–deficient counter-
part DU1090. (E) Coomassie-stained SDS-PAGE of a highly purified 
(lane 2) and the commercially available (lane 3)  -toxin prepara-
tion. The molecular sizes of the protein marker used in lane 1 are 
indicated on the left. (F) Jurkat cells were incubated with the
indicated concentrations of the two  -toxin preparations, and cell 
death was assessed after 24 h.640 The Journal of Cell Biology | Volume 155, Number 4, 2001
antibody completely blocked  -toxin– and Wood 46–
induced caspase-3 activation (Fig. 3, B and C, respectively).
On the other hand, activation of caspase-3 induced by the
agonistic anti-CD95 antibody was not affected, demonstrat-
ing again the specificity of the anti– -toxin antibody (Fig. 3
D). Consistent with our results shown in Fig. 2 A, the anti-
body could also not inhibit caspase-3 activation when higher
( 1  g/ml)  -toxin concentrations were used (Fig. 3 B).
Similar results were obtained with supernatant of the S. au-
reus strain Wood 46 (Fig. 3 C) and the highly purified
 -toxin, which induced caspase-3 activation in these cells
with an almost identical dose dependency as the commer-
cially available preparation (unpublished data).
Western blot analysis confirmed these results, showing
that treatment of Jurkat cells with supernatant of Wood 46
resulted in the rapid conversion of the inactive 32 kD cas-
pase-3 precursor into the proteolytically active p17 subunit,
indicating that caspase-3 was indeed activated during S. au-
reus–induced apoptosis (Fig. 4 A, top). Similar results were
obtained when  -toxin was used as the death stimulus (un-
published data). In both cases, the appearance of the active
p17 caspase-3 subunit was abrogated completely in the pres-
ence of the anti– -toxin antibody (unpublished data), dem-
onstrating that caspase-3 activation was induced by  -toxin.
In agreement with the DEVDase assays (Figs. 3, A and C),
caspase-3 activation peaked at lower Wood 46 concentra-
tions (0.06% supernatant) and declined rapidly when higher
concentrations were used (Fig. 4 A, top). Furthermore, cas-
pase-3 activation correlated directly with cleavage of the
death substrate  -fodrin into the 120-kD fragment (Fig. 4
A, bottom) and the appearance of the characteristic DNA
ladder formation (Fig. 4 B), both of which could be inhib-
ited completely by the anti– -toxin antibody (unpublished
data). Since it was shown recently that active caspase-3 is ab-
solutely required for the induction of both these events
(Jänicke et al., 1998a,b), our results clearly demonstrate that
S. aureus–induced cell death and caspase activation are me-
diated by  -toxin.
 -Toxin induces caspase-3 activation in lymphocytes 
and monocytes
Infection with S. aureus is accompanied by the death of im-
mune competent cells including T cells and monocytes
(Weinrauch and Zychlinsky, 1999; Gao and Kwaik, 2000).
To analyze the role of  -toxin in this respect and to establish
a more general mechanism on various clinically relevant cell
types, human PBLs and monocytes were incubated for the
indicated times with various concentrations of the two  -toxin
preparations. As shown in Fig. 5, caspase-3 was activated ef-
ficiently in PBL and monocytes by both  -toxin prepara-
tions in a time- and dose-dependent manner. Similar to the
results obtained with Jurkat cells (Fig. 2 F; unpublished
data), both  -toxin preparations induced activation of cas-
pase-3 in PBL or monocytes with almost identical efficien-
cies, indicating that  -toxin might contribute to cell death
observed after S. aureus infection.
 -Toxin activates the initiator caspases 8 and 9
Caspase-3 activation can be achieved either by caspase-8, the
most proximal caspase in death receptor signaling, or by cas-
pase-9, the initiator caspase of the mitochondrial pathway.
To elucidate which of these two pathways is responsible for
 -toxin–induced caspase-3 activation, extracts of Wood 46–
treated Jurkat cells were analyzed for their capability to
cleave the fluorogenic substrates N-acetyl-Ile-Glu-Thr-Asp
(IETD)-AMC and N-acetyl-Leu-Glu-His-Asp (LEHD)-
AMC, which are indicative of caspase-8 and -9 activity, re-
spectively. In addition, Western blot analyses were performed.
Similar to caspase-3 activation (Fig. 3), Wood 46 induced a
Figure 3. S. aureus–induced caspase-3 activation is mediated by 
 -toxin. (A) DEVDase activity in extracts of Jurkat cells incubated 
for 4 h with the indicated supernatant dilutions of the various 
S. aureus strains. (B–D) DEVDase activity in extracts of Jurkat cells 
incubated for 4 h with the indicated concentrations of  -toxin (B), 
Wood 46 supernatant (SN) (C), or the agonistic anti-CD95 antibody 
(D) in the absence or presence of the neutralizing sheep anti–
 -toxin antiserum (1:100). The dashed line (control) represents the 
DEVDase activity in untreated cells.
Figure 4. S. aureus–induced caspase-3 activation results in 
 -fodrin cleavage and DNA fragmentation. (A) Western blot 
analyses demonstrating caspase-3 processing (top) and  -fodrin 
cleavage (bottom) in Jurkat cells that were either left untreated 
(control) or incubated for 4 h with the indicated dilutions of Wood 
46 supernatant (SN). (B) Agarose gel electrophoretic separation of 
DNA extracted from Jurkat cells that were either left untreated 
(control) or incubated for 6 h with the indicated dilutions of Wood 
46 supernatant (SN). The positions of the DNA molecular size 
marker are indicated on the right.S. aureus  -toxin activates the intrinsic death pathway | Bantel et al. 641
dose-dependent increase of IETDase and LEHDase activity
in Jurkat cells (Fig. 6 A). These enzymatic activities corre-
lated well with the appearance of the p41/p43-processed cas-
pase-8 subunits (Fig. 6 B, top) and the p37 active caspase-9
fragment, respectively (Fig. 6 B, bottom). Wood 46–induced
caspase-8 and -9 activation reached a peak when 0.06% of
the supernatant was used and declined rapidly with higher
concentrations, which is reminiscent of the activation profile
of caspase-3 (Fig. 3 C and Fig. 4 A). Similar results were ob-
tained with purified  -toxin (unpublished data), indicating
that both caspase-8 and caspase-9 are involved in S. aureus–
mediated cytotoxicity.
S. aureus mediates cell death and caspase-8 activation 
independently of CD95 and death receptor signaling
Caspase-8 has been identified originally as the most apical
caspase in apoptosis mediated by the surface receptor CD95.
Therefore, we asked whether a functional CD95 pathway is
essential for S. aureus–induced caspase-8 activation and T
cell apoptosis. For this purpose, Jurkat subclones with vari-
ous deficiencies in crucial CD95 signaling components that
rendered these cells resistant towards CD95-mediated apop-
tosis (Fig. 7 B) were analyzed for their capability to undergo
cell death after treatment with supernatant of the S. aureus
strain RN6390. Like Jurkat wild-type cells, Jurkat-R cells
that have lost CD95 expression due to continuous culture
with the agonistic anti-CD95 antibody were killed effi-
ciently by RN6390 in a dose-dependent manner (Fig. 7 A).
Also FADD- or caspase-8–deficient Jurkat cells were killed
to a similar extent compared with Jurkat wild-type cells (Fig.
7 A). Together, these findings demonstrate that neither
CD95/CD95L interaction nor other FADD-dependent
death receptors are required for S. aureus–induced apoptosis
and even indicate that caspase-8 itself, although activated,
may not be essential for this process.
Next, we examined the influence of the CD95 signaling
pathway on the S. aureus–mediated activation of the effector
caspase-3. As shown in Fig. 7 C, activation of caspase-3 was
also achieved via a CD95-independent pathway, since
RN6390 induced DEVDase activity in Jurkat-R cells and
even in caspase-8–deficient cells to a similar extent as in Jur-
kat wild-type cells. Only FADD-deficient cells displayed a
slight delay in RN6390-induced caspase-3 activation (Fig. 7
C). Similar results were obtained with supernatant of the S.
aureus strain Wood 46 and purified  -toxin (unpublished
data). As a control, the various Jurkat subclones were treated
with the anti-CD95 antibody, which did not result in an en-
hancement of DEVDase activity, confirming that these
components are essential for caspase-3 activation in the
CD95 signaling pathway (Fig. 7 D). In contrast, the chemo-
therapeutic drug etoposide, which is known to mediate
apoptosis independently of the death receptor pathway, in-
duced similar levels of caspase-3 activity in all Jurkat sub-
lines, ruling out a general defect in the apoptosis pathways in
these cells (Fig. 7 D).
Figure 5. S. aureus  -toxin induces caspase-3 activation in human 
PBL and monocytes. DEVDase activity in extracts of PBL (A and B) 
and monocytes (C and D). Cells were either incubated for 4 h with 
the indicated  -toxin concentrations (A and C) or with 30 ng/ml 
 -toxin for the indicated times (B and D).
Figure 6. S. aureus induces activation of the initiator caspases 8 
and 9. (A) Jurkat cells were incubated with the indicated dilutions of 
Wood 46 supernatant (SN). After 4 h, cell extracts were prepared and 
analyzed for caspase activity using the fluorogenic substrates IETD 
AMC for caspase 8 ( ) and LEHD AMC for caspase 9 ( ). The two 
dashed lines represent IETDase and LEHDase activity in untreated 
cells. (B) Western blot analysis of the status of caspase-8 (top) and 
caspase-9 (bottom) in Jurkat cells that were either left untreated 
(control) or incubated for 4 h with the indicated dilutions of Wood 46 
supernatant (SN). The uncleaved proforms and the p43/p41 fragments 
of caspase-8 and the p37 fragment of caspase-9 are indicated.642 The Journal of Cell Biology | Volume 155, Number 4, 2001
Although we have shown that the CD95 signaling path-
way is not required for S. aureus–induced cell death, cas-
pase-8 is activated and hence appears to be involved (Fig. 6).
To solve this apparent discrepancy, we investigated more
closely the role of caspase-8 in this process. As demonstrated
by Western blot analyses,  -toxin (Fig. 7 E) and supernatant
of the S. aureus strain Wood 46 (unpublished data) induced
caspase-8 processing into the p41/p43 subunits in both Jur-
kat-R and FADD-deficient cells in a similar dose-dependent
manner as observed in Jurkat wild-type cells (Fig. 6 B).
These results clearly indicate that a functional CD95 death
pathway is not required for S. aureus– and  -toxin–medi-
ated caspase-8 activation. As expected, etoposide also in-
duced caspase-8 processing in both Jurkat-R– and Jurkat
FADD-deficient cells, whereas treatment of the cells with
the agonistic anti-CD95 antibody had no effect (Fig. 7 E).
Bcl-2 inhibits S. aureus–mediated cell death and 
caspase activation
Next, we examined the possibility that caspase activation
by S. aureus is mediated via the intrinsic death pathway.
For this purpose, Jurkat cells stably expressing the antiap-
optotic protein Bcl-2 that is known to prevent mitochon-
drial cytochrome c release were incubated with increasing
concentrations of Wood 46 (Fig. 8 A) or RN6390 (Fig. 8
B) supernatants. Cell death was inhibited dose depen-
dently in Jurkat Bcl-2 cells compared with similarly treated
Jurkat vector cells. However, cell death inhibition was ob-
served only when low concentrations of S. aureus culture
supernatants were used, whereas cell death induced with
higher concentrations of Wood 46 or RN6390 superna-
tants was not affected by Bcl-2. This is consistent with our
previous results, demonstrating that only low concentra-
Figure 7. S. aureus  -toxin signals cell death and caspase activa-
tion independently of death receptor pathways. Assessment of cell 
death (A and B) and DEVDase activity (C and D) in Jurkat cells ( ), 
Jurkat-R cells ( ), FADD-deficient Jurkat cells ( ), and caspase-8–
deficient Jurkat cells ( ). Cells were incubated with increasing 
concentrations of RN6390 supernatant (A and C), anti-CD95 (B and 
D), or etoposide (D). (E) Western blot analyses demonstrating the 
activation of caspase-8 in Jurkat-R cells (top) and FADD-deficient 
cells (bottom) that were either left untreated (control) or incubated 
for 4 h with the indicated concentrations of  -toxin. As a control, 
cells were treated for 4 h with anti-CD95 or etoposide. The blots 
show the uncleaved precursor forms and the p43/p41 intermediate 
fragments of caspase-8.
Figure 8. S. aureus mediates cell death and caspase activation via 
the Bcl-2–controlled mitochondrial death pathway. Assessment of 
cell death (A and B) and caspase-3–like activity (D and E) in Jurkat 
vector control cells ( ) or cells overexpressing Bcl-2 ( ). Cells were 
incubated with increasing concentrations of Wood 46 supernatant 
(A and D), RN6390 supernatant (B), or  -toxin (E). Assessment of 
etoposide- or CD95-induced apoptosis (C) and DEVDase activity (F) 
in vector cells (filled bars) and Bcl-2 cells (open bars) served as 
controls. Cell death and DEVDase activity were determined after 24 
and 4 h, respectively.S. aureus  -toxin activates the intrinsic death pathway | Bantel et al. 643
tions of S. aureus culture supernatants induce caspase acti-
vation (Figs. 3, 4, and 6).
Similarly, almost no DEVDase activity could be detected
in Bcl-2–overexpressing Jurkat cells treated with supernatant
of Wood 46 (Fig. 8 D) or  -toxin (Fig. 8 E), confirming
that S. aureus–induced caspase activation and cell death are
mediated via the mitochondrial pathway. As a control, eto-
poside-induced apoptosis and caspase activation that require
the intrinsic death pathway were almost completely abro-
gated in Bcl-2–overexpressing cells, whereas CD95-medi-
ated signaling was not affected (Fig. 8, C and F).
 -Toxin induces cytochrome c release in intact cells 
and isolated mitochondria
To further examine the S. aureus–induced caspase activation
pathway, we monitored the release of mitochondrial cyto-
chrome c from Jurkat cells incubated for various times with
 -toxin. Western blot analysis showed a time-dependent in-
crease of cytochrome c release, which was first, although
only marginally, visible after a 2-h exposure of the cells to
 -toxin (Fig. 9 A). Nevertheless, continuous exposure of the
cells to  -toxin resulted in increasing cytosolic cytochrome c
levels that were comparable to those released after an 8-h
treatment of cells with the kinase inhibitor staurosporine.
We then asked whether  -toxin has a direct effect on mito-
chondria. Isolated mitochondria from Jurkat cells were incu-
bated for 30 min with various concentrations of  -toxin, and
the supernatants were analyzed by Western blotting for their
cytochrome c content. As shown in Fig. 9 B,  -toxin induced
a dose-dependent release of cytochrome c from isolated mito-
chondria. The amount of cytochrome c released after  -toxin
treatment was comparable to the level of cytochrome c release
achieved by incubation of the mitochondria with betulinic
acid, a potent cell death inducer with a direct effect on mito-
chondria (Fulda et al., 1998). No cytochrome c was released
when the mitochondria were treated with supernatant of the
non–cytotoxic S. carnosus strain TM300 (unpublished data).
More importantly, both betulinic acid and  -toxin did not
induce cytochrome c release from mitochondria isolated from
Bcl-2–overexpressing Jurkat cells (Fig. 9 B), demonstrating
that  -toxin can directly target mitochondria in a Bcl-2–con-
trolled manner. Interestingly, Bcl-2 prevented breakdown of
the mitochondrial membrane potential only when low doses
of  -toxin were used but had a weaker effect with high
 -toxin concentrations (Fig. 9 C). Nevertheless, our data
clearly demonstrate that  -toxin is a mediator of S. aureus–
induced cell death that triggers caspase activation in Jurkat T
cells via mitochondrial cytochrome c release independently of
death receptor pathways.
Discussion
Several pathogens, including Salmonella typhimurium, Heli-
cobacter pylori, Neisseria gonorrhoeae, Listeria monocytogenes,
and Yersinia enterocolitica, are able to trigger apoptosis of
mammalian host cells, whereas others such as Rickettsia spp.
and Chlamydia spp. have been reported to exert antiapop-
totic effects (Weinrauch and Zychlinsky, 1999; Gao and
Kwaik, 2000). However, in most cases the underlying mo-
lecular processes and their relevance to host pathogen inter-
actions remain largely unknown. In the present study, we
have delineated the mechanisms of S. aureus–induced T cell
apoptosis. We show that apoptosis in response to S. aureus
infection can be triggered by a soluble factor,  -toxin, which
mediates caspase activation via the mitochondrial apoptosis
pathway. Interestingly,  -toxin was able to induce cyto-
chrome c release not only in intact cells but also from iso-
lated mitochondria in a Bcl-2–controlled manner, suggest-
ing that at least part of its cytotoxicity is mediated by a direct
proapoptotic mechanism.
The ability of S. aureus to induce apoptosis has been no-
ticed previously in a variety of cell types including epithelial
cells, endothelial cells, keratinocytes, osteoblasts, lympho-
cytes, and macrophages (Jonas et al., 1994; Bayles et al.,
1998; Menzies and Kourteva, 1998, 2000; Kahl et al., 2000,
Nuzzo et al., 2000; Tucker et al., 2000). Induction of apop-
tosis by S. aureus may cause tissue damage, compromise the
Figure 9. S. aureus  -toxin induces cytochrome c release in intact 
cells and isolated mitochondria in a Bcl-2–controlled manner. (A) 
Western blot analysis of cytosolic cytochrome c in Jurkat cells 
treated for the indicated times with 0.03  g/ml  -toxin or for 8 h 
with 1  g/ml staurosporine (Stauro). (B) Effect of  -toxin on isolated 
mitochondria. Isolated mitochondria from Jurkat (lanes 1–7) or from 
Bcl-2–overexpressing Jurkat cells (lanes 8–14) were incubated for 
30 min with a buffer control (lanes 2 and 9), 10  g/ml betulinic acid 
(lanes 3 and 10), or the indicated concentrations of  -toxin (lanes 
4–7 and 11–14). The release of cytochrome c was detected by 
immunoblotting. Lanes 1 and 8 (total mitos) represent the complete 
amount of cytochrome c present in mitochondria from Jurkat and 
Jurkat Bcl-2 cells, respectively. (C) Measurement of the mitochon-
drial transmembrane potential (  m) in untreated (Control) Jurkat 
and Jurkat Bcl-2 cells or in cells treated for 4 h with etoposide or the 
indicated concentrations of  -toxin.644 The Journal of Cell Biology | Volume 155, Number 4, 2001
antimicrobial immune response, and thereby promote bacte-
rial spread. Although S. aureus is classically considered as an
extracellular pathogen, it can invade a number of different
cell types (Sinha et al., 1999). In some cell types, such as ep-
ithelial cells, keratinocytes, or osteoblasts, S. aureus–induced
apoptosis has been proposed to require the prior internaliza-
tion of bacteria (Bayles et al., 1998; Menzies and Kourteva,
1998; Kahl et al., 2000, Nuzzo et al., 2000; Tucker et al.,
2000). Contrary to these reports, our data clearly show that
in T cells bacterial invasion is not required and that soluble
 -toxin is a mediator of S. aureus–induced apoptosis. This
finding is supported by several independent observations: (a)
we noticed that the cytotoxicity of different S. aureus strains
correlated with the expression levels of  -toxin; (b) we show
that an identical pattern of apoptosis was obtained using ei-
ther intact bacteria, bacterial supernatants, or  -toxin; (c)
apoptosis induction did not occur with the bacterial super-
natant of an  -toxin knock-out strain; and most importantly
(d) the cytotoxic activity of  -toxin or the bacterial superna-
tants was abolished completely by two different neutralizing
 -toxin antibodies. Although we detected minor impurities
in the commercially available  -toxin, this preparation in-
duced cell death and caspase activation with an almost iden-
tical dose dependency as achieved with highly purified
 -toxin. Moreover, both  -toxin preparations efficiently in-
duced caspase-3 activation in human PBLs and monocytes
with a similar dose dependency. Thus, our data are in line
with a recent report suggesting that  -toxin is necessary for
apoptosis induction also in endothelial cells (Menzies and
Kourteva, 2000) and thereby underscore the pathophysio-
logical function of S. aureus  -toxin, which might explain
the death of immune cells during sepsis. However, since the
cellular systems used in this study might not accurately re-
flect the host–parasite interactions in an infected animal we
cannot exclude additional staphylococcal exoproteins that
might contribute to cell death induction in vivo.
Interestingly, we found that caspase activation and subse-
quent DNA fragmentation were only triggered at low con-
centrations of  -toxin, whereas higher concentrations did
not induce apoptotic alterations. These differences may be
directly related to the molecular properties of  -toxin. At
low doses, the toxin binds to specific as yet unidentified cell
surface receptors and produces small heptameric pores that
selectively facilitate the release of monovalent ions, resulting
in DNA fragmentation and apoptosis (Jonas et al., 1994;
Song et al., 1996; Valeva et al., 1997). However, at high
doses ( 6   g/ml)   -toxin nonspecifically adsorbs to the
lipid bilayer, forming larger pores that are Ca
2  permissive,
which results in massive necrosis. Moreover, the larger pores
will also lead to the loss of ATP, which is required for most
apoptotic processes (Leist et al., 1997; Ferrari et al., 1998).
Thus, the modes of cell death may critically depend on the
concentration of  -toxin.
S. aureus and  -toxin did not only induce the activation of
effector caspase-3 but also of caspase-8 and -9, the two ma-
jor initiator caspases. The activation of caspase-8 might be
indicative for the involvement of CD95 as suggested re-
cently for S. aureus–induced apoptosis in mammary epithe-
lial cells (Wesson et al., 2000). Moreover, S. aureus–induced
apoptosis of monocytes has been proposed to involve CD95
signaling caused by the upregulation of CD95 ligand expres-
sion (Baran et al., 2001). However, in three different Jurkat
cell clones that are completely resistant against CD95 but
sensitive towards anticancer drug-induced apoptosis (this
study; Wesselborg et al., 1999; Engels et al., 2000),  -toxin
induced apoptosis with a similar dose response as in paren-
tal cells. Thus, in contrast to other bacteria, including
Pseudomonas aeruginosa (Grassme et al., 2000) and Helico-
bacter pylori (Rudi et al., 1998), our data clearly indicate that
neither CD95 or other FADD-dependent death receptors
are required for S. aureus–induced cytotoxicity in T cells.
Since death receptors were obviously not involved in S.
aureus–induced cell death, we investigated the role of mito-
chondria. An early event in this pathway is the proapoptotic
translocation of mitochondrial cytochrome c into the cyto-
sol, which is inhibited by antiapoptotic Bcl-2 proteins
(Kluck et al., 1997; Yang et al., 1997). Indeed, in cells over-
expressing Bcl-2, S. aureus–mediated apoptosis and caspase
activation were suppressed significantly compared with con-
trol cells. Moreover, S. aureus  -toxin caused a time-depen-
dent redistribution of cytochrome c, which was associated
with proteolytic processing of caspase-9 and subsequent acti-
vation of effector caspases. The mitochondrial activation of
caspase-9 and -3 was also presumably responsible for the ac-
tivation of caspase-8 by S. aureus. We have shown recently
that during drug-induced apoptosis caspase-8 activation is a
postmitochondrial event downstream of caspase-3 (Engels et
al., 2000). In this scenario, caspase-8 might induce Bid acti-
vation and enforce cytochrome c release, thereby amplifying
the apoptotic cascade.
A surprising observation was the fact that  -toxin did not
only induce cytochrome c release in intact cells but also from
isolated mitochondria in a Bcl-2–controlled manner. A rapid
and dose-dependent release of cytochrome c from isolated
mitochondria was observed already with low doses of
 -toxin, whereas supernatants of the bacterial strain TM300
that failed to induce apoptosis also did not induce cyto-
chrome c release in vitro. Interestingly, caspase activation,
DNA fragmentation, and cytochrome c release induced with
low  -toxin doses were blocked completely by Bcl-2, whereas
cell death induced with high  -toxin concentrations pro-
ceeded independently of mitochondria-mediated caspase ac-
tivation. The reason for this phenomenon is presently un-
known but is consistent with our observation that also
breakdown of the mitochondrial membrane potential was
prevented only by Bcl-2 when low  -toxin doses were em-
ployed. This latter finding is in agreement with several re-
ports showing that the loss of the mitochondrial membrane
potential is a late event in apoptosis not associated necessarily
with cytochrome c release (Bossy-Wetzel et al., 1998; Gold-
stein et al., 2000; Kroemer and Reed, 2000). Nonetheless,
our data suggest that  -toxin may directly target mitochon-
dria, a mechanism that has also been described recently for
VacA, the vacuolating cytotoxin of Helicobacter pylori (Gal-
miche et al., 2000) and the Neisseria gonorrhoeae porin PorB
(Müller et al., 2000). It is interesting to note that N. gonor-
rhoeae PorB and S. aureus  -toxin have similar three-dimen-
sional structures consisting of antiparallel  -barrels; both tox-
ins also have the ability to insert necessarily into artificial
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Therefore, our results suggest that S. aureus  -toxin might
induce apoptosis by two separate mechanisms. First, inser-
tion of  -toxin into the plasma membrane and subsequent
pore formation will lead to K
  efflux and Na
  influx. The
depletion of potassium ions may cause caspase activation as it
has been observed in monocytes treated with depolarizing
drugs such as nigericin (Warny and Kelly, 1999). Secondly,
 -toxin might translocate to the outer mitochondrial mem-
brane and trigger cytochrome c release. One may speculate
that the direct targeting of mitochondria by  -toxin may be
important, particularly in those cell types in which apoptosis
requires the prior internalization of S. aureus.
In conclusion, our data demonstrate that S. aureus  -toxin
induces caspase activation and apoptosis through mitochondrial
cytochrome c release independently of death receptor signaling.
These findings open promising insights into how S. aureus me-
diates cytotoxicity and may provide a molecular rationale for fu-
ture therapeutic interventions in bacterial infections.
Materials and methods
Jurkat cell lines, reagents, and antibodies
All cell lines were maintained in RPMI 1640 supplemented with 10% heat-
inactivated FCS, 10 mM glutamine, and 50  g/ml of each streptomycin and
penicillin/ml (all from GIBCO BRL). The Jurkat sublines Jurkat-R and the
FADD- and caspase-8–deficient Jurkat cells were described previously (Juo et
al., 1998; Wesselborg et al., 1999). Jurkat cells stably transfected with Bcl-2
or empty vector were from H. Walczak (Deutsche Krebsforschungszentrum,
Heidelberg, Germany). Aprotinin, antipain, pepstatin, leupeptin, and PMSF,
etoposide, RNase A, proteinase K, S. aureus  -toxin, and the neutralizing
polyclonal rabbit anti– -toxin antibody were purchased from Sigma-Aldrich.
The anti-CD95 mAb (IgG3; BioCheck) and etoposide were used at concentra-
tions of 1  g/ml and 100  M, respectively. The highly purified  -toxin prepa-
ration was a generous gift from A. Valeva and S. Bhakdi (Institute of Medical
Microbiology and Hygiene, Mainz, Germany). Recombinant lysostaphin was
obtained from WAK Chemie/Applied Microbiology. Human serum albumin
was from Behring. The fluorogenic caspase substrates DEVD-AMC, IETD-
AMC, and LEHD-AMC were from Biomol. Neutralizing polyclonal sheep
anti– -toxin was from Toxin Technology, and monoclonal anti–caspase-8
was from BioCheck. The polyclonal goat and rabbit antibodies recognizing
caspase-3 and caspase-9 were from R&D Systems and New England Biolabs,
Inc., respectively. Anti– -fodrin (mAb1622) was purchased from Chemicon,
and anti–cytochrome c (mAb7H8.2C12) was from PharMingen.
Isolation and culture of PBL and monocytes
Human PBLs and monocytes were isolated by standard Ficoll-Paque (Am-
ersham Pharmacia Biotech) and subsequent Percoll gradient centrifugation
from heparin-treated blood of healthy donors. Purity of monocytes and
lymphocytes was confirmed by FACS
® analyses using CD14 and CD3 anti-
bodies, respectively, and was  90%.
Bacterial strains, cultures, and supernatants
The properties and source of all the bacterial strains used in this study are
listed in Table I. DU5883 is an isogenic mutant of 8325-4 with the dele-
tions (by allelic replacement) in fnbA and fnbB encoding fibronectin-bind-
ing proteins A and B, respectively. DU1090 is an isogenic mutant of 8325-
4 with a deletion (by allelic replacement) in hla, the gene for  -toxin. All
mutants were provided by T. Foster (Moyne Institute of Preventive Medi-
cine, Dublin, Ireland). Bacteria were grown in 5 ml of brain-heart-infusion
broth (Merck) in 25-ml glass tubes on a rotatory shaker (200 rpm) at 37 C
for 12–14 h and pelleted for 5 min at 3,350 g. Supernatants were filtered
through a Millex-GP filter unit (0.22  m; Millipore), resuspended in PBS/
1% human serum albumin, and kept on ice. Sterility and actual concentra-
tion of viable bacteria were assayed by plating appropriate serial dilutions
on tryptic soy agar plates followed by manual counting.
Preparation of cell extracts and Western blotting
Cell extracts were prepared as described (Jänicke et al., 1998a). To confirm
equal loading, protein concentrations were determined with the Bio-Rad
Laboratories protein assay. Proteins were separated in SDS-polyacrylamide
gels and subjected to Western blotting. The proteins were visualized by
enhanced chemiluminescent staining using ECL reagents (Amersham Phar-
macia Biotech).
Detection of DNA fragmentation
The proportion of nuclei containing hypodiploid DNA was assessed after
24 h by the method of Nicoletti et al. (1991) with minor modifications as
described (Wesselborg et al., 1999; Engels et al., 2000).
DNA fragmentation was also assessed using agarose gel electrophoresis.
DNA was prepared by lysing 5   10
6 Jurkat cells in 0.2 ml of 0.5   TE
buffer (20 mM Tris, 0.5 mM EDTA, pH 8.0) containing 0.25% NP-40 and 50
 g RNase A at 37 C for 30 min. Proteinase K (200  g/sample) was added,
and the samples were incubated for another 30 min at 37 C. DNA sample
buffer was added, and aliquots were analyzed on 1.6% agarose gels.
Fluorometric determination of caspase-3, -8, or -9 activities
Caspase activities were determined by incubation of cell lysates with 50
 M of the fluorogenic substrates DEVD-AMC for caspase-3, IETD-AMC for
caspase-8, or LEHD-AMC for caspase-9 in 200  l buffer containing 50 mM
Hepes, pH 7.4, 100 mM NaCl, 10% sucrose, 0.1% CHAPS, and 10 mM
DTT. The release of aminomethyl-coumarin was measured by fluorometry
(FL600; Bio-Tek Instruments) using an excitation wavelength of 360 nm
and an emission wavelength of 475 nm. The catalytic activities are given
in arbitrary units (AU).
Isolation of the mitochondria-enriched heavy membrane 
fraction and measurement of cytochrome c release
Enrichment of mitochondria was achieved by permeabilizing 2   10
8 Jur-
kat cells for 5 min in a buffer containing 100  g/ml digitonin, 250 mM su-
crose, 20 mM Hepes, pH 7.4, 1.5 mM MgCl2, 10 mM KCl, 1 mM EDTA, 1
mM EGTA, 1 mM DTT, 1 mM PMSF, and 10  g/ml of each of the pro-
tease inhibitors aprotinin, pepstatin, and leupeptin. Cells were centri-
fuged at 200 g for 10 min at 4 C to remove cell nuclei. The supernatant
was transferred to a fresh tube and centrifuged at 10,000 g for 15 min at
4 C. The pelleted mitochondria were washed twice with the same buffer
without digitonin, EGTA, and EDTA. 10  l of the mitochondria suspen-
sion were incubated for 30 min at 37 C with the indicated stimuli and
pelleted by centrifugation. The supernatants were loaded on a 15% SDS-
polyacrylamide gel and analyzed by immunoblotting. To monitor cyto-
chrome c release in Jurkat cells,  4   10
6 cells were cultured for the in-
dicated times in the presence or absence of 0.03  g/ml  -toxin, washed,
and resuspended in 200  l of the above mentioned buffer. After 5 min at
4 C, cells were centrifuged at 1,000 g for 10 min to remove cell nuclei
Table I. Bacterial strains used in this study
Strain Relevant genotype Properties Source
S. aureus
Cowan I National Collection of Type Cultures 8530 (septic arthritis) American Type Culture Collection 12589
8325-4 National Collection of Type Cultures 8325 cured of prophages McDevitt et al., 1994; Greene et al., 1995
DU5883 8325-4 fnbA fnbB FnBPA -, FnBPB - Greene et al., 1995
DU1090 8325-4 hla  -Toxin - O’Reilly et al., 1986
RN6390 Wild-type 8325-4 strain Novick et al., 1993
Wood 46 Strong  -toxin producer, protein A - National Collection of Type Cultures 10344
6850 Clinical isolate (osteomyelitis) Balwit et al., 1994
S. carnosus
TM300 No expression of toxins Schleifer and Fischer, 1982646 The Journal of Cell Biology | Volume 155, Number 4, 2001
and at 10,000 g for 15 min to remove mitochondria. The resulting super-
natants were analyzed for cytochrome c content as described above.
Determination of the mitochondrial transmembrane potential
The mitochondrial transmembrane potential (  m) was analyzed using
the   m-specific stain TMRE (Molecular Probes). In brief, 10
5 cells were
stained after 4 h in a solution containing 25 nM TMRE for 10 min. Staining
was quantified by FL2 and scatter characteristics using a flow cytometer.
The authors wish to thank A. Valeva and S. Bhakdi for the purified  -toxin
preparation, and J. Blenis, H. Walczak, T.J. Foster, and F. Götz for provid-
ing materials and helpful discussions. In addition, we would like to thank
A. Zeipert for excellent technical assistance.
This work was supported by grants from the Interdisciplinary Center of
Clinical Research (IZKF C13/D13) of the University of Münster and the
Deutsche Forschungsgemeinschaft (Schu 1180/2-1, SFB 293-A6). B. Sinha
was supported by a fellowship from the German Bundesministerium für
Forschung und Technologie.
Submitted: 16 May 2001
Revised: 3 October 2001
Accepted: 3 October 2001
References
Balwit, J.M., P. van Langevelde, J.M. Vann, and R.A. Proctor. 1994. Gentamicin-
resistant menadione and hemin auxotrophic Staphylococcus aureus persist
within cultured endothelial cells. J. Infect. Dis. 170:1033–1037.
Baran, J., K. Weglarczyk, M. Mysiak, K. Guzik, M. Ernst, H.D. Flad, and J.
Pryjma. 2001. Fas (CD95)-Fas ligand interactions are responsible for mono-
cyte apoptosis occurring as a result of phagocytosis and killing of Staphylococ-
cus aureus. Infect. Immun. 69:1287–1297.
Bayles, K.W., C.A. Wesson, L.E. Liou, L.K. Fox, G.A. Bohach, and W.R. Trum-
ble. 1998. Intracellular Staphylococcus aureus escapes the endosome and in-
duces apoptosis in epithelial cells. Infect. Immun. 66:336–342.
Bossy-Wetzel, E., D.D. Newmeyer, and D.R. Green. 1998. Mitochondrial cyto-
chrome c release in apoptosis occurs upstream of DEVD-specific caspase ac-
tivation and independently of mitochondrial transmembrane depolarization.
EMBO J. 17:37–49.
Boya, P., B. Roques, and G. Kroemer. 2001. Viral and bacterial proteins regulating
apoptosis at the mitochondrial level. EMBO J. 20:4325–4331.
Cohen, G.M. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326:1–16.
Cryns, V., and J. Yuan. 1998. Proteases to die for. Genes Dev. 12:1551–1570.
Engels, I.H., A. Stepczynska, C. Stroh, K. Lauber, C. Berg, R. Schwenzer, H. Wa-
jant, R.U. Jänicke, A.G. Porter, C. Belka, et al. 2000. Caspase-8/FLICE
functions as an executioner caspase in anticancer drug-induced apoptosis.
Oncogene. 19:4563–4573.
Fulda, S., C. Scaffidi, S.A. Susin, P.H. Krammer, G. Kroemer, M.E. Peter, and
K.M. Debatin. 1998. Activation of mitochondria and release of mitochon-
drial apoptogenic factors by betulinic acid. J. Cell Biol. 273:33942–33948.
Ferrari, D., A. Stepczynska, M. Los, S. Wesselborg, and K. Schulze-Osthoff. 1998.
Differential regulation and ATP requirement for caspase-8 and caspase-3 ac-
tivation during CD95- and anticancer drug-induced apoptosis. J. Exp. Med.
188:979–984.
Galmiche, A., J. Rassow, A. Doye, S. Cagnol, J.C. Chambard, S. Contamin, V. de
Thillot, I. Just, V. Ricci, E. Solcia, et al. 2000. The N-terminal 34 kDa frag-
ment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and
induces cytochrome c release. EMBO J. 19:6361–6370.
Gao, L.-Y., and Y.A. Kwaik. 2000. Hijacking of apoptotic pathways by bacterial
pathogens. Microbes Infect. 2:1705–1719.
Goldstein, J.C., N.J. Waterhouse, P. Juin, G.I. Evan, and D.R. Green. 2000. The
coordinate release of cytochrome c during apoptosis is rapid, complete and
kinetically invariant. Nat. Cell Biol. 2:156–162.
Grassme, H., S. Kirschnek, J. Riethmueller, A. Riehle, G. von Kurthy, F. Lang, M.
Weller, and E. Gulbins. 2000. CD95/CD95 ligand interactions on epithe-
lial cells in host defense to Pseudomonas aeruginosa. Science. 290:527–530.
Greene, C., D. McDevitt, P. Francois, P.E. Vaudaux, D.P. Lew, and T.J. Foster.
1995. Adhesion properties of mutants of Staphylococcus aureus defective in fi-
bronectin-binding proteins and studies on the expression of fnb genes. Mol.
Microbiol. 17:1143–1152.
Jänicke, R.U., P. Ng, M.L. Sprengart, and A.G. Porter. 1998a. Caspase-3 is re-
quired for  -fodrin cleavage but dispensable for cleavage of other death sub-
strates in apoptosis. J. Biol. Chem. 273:15540–15545.
Jänicke, R.U., M.L. Sprengart, M.R. Wati, and A.G. Porter. 1998b. Caspase-3 is
required for DNA fragmentation and morphological changes associated with
apoptosis. J. Biol. Chem. 273:9357–9360.
Jonas, D., I. Walev, T. Berger, M. Liebetrau, M. Palmer, and S. Bhakdi. 1994.
Novel path to apoptosis: small transmembrane pores created by staphylococ-
cal  -toxin in T lymphocytes evoke internucleosomal DNA degradation. In-
fect. Immun. 62:1304–1312.
Juo, P., C.J. Juo, J. Yuan, and J. Blenis. 1998. Essential requirement for caspase-8/
FLICE in the initiation of the Fas-induced apoptotic cascade. Curr. Biol.
8:1001–1008.
Kahl, B.C., M. Goulian, W. van Wamel, M. Herrmann, S.M. Simon, G. Kaplan,
G. Peters, and A.L. Cheung. 2000. Staphylococcus aureus RN6390 replicates
and induces apoptosis in a pulmonary epithelial cell line. Infect. Immun. 68:
5385–5392.
Kluck, R.M., E. Bossy-Wetzel, D.R. Green, and D.D. Newmeyer. 1997. The re-
lease of cytochrome c from mitochondria: a primary site for Bcl-2 regulation
of apoptosis. Science. 275:1132–1136.
Kroemer, G., and J.C. Reed. 2000. Mitochondrial control of cell death. Nat. Med.
6:513–519.
Leist, M., B. Single, A.F. Castoldi, S. Kühnle, and P. Nicotera. 1997. Intracellular
adenosine triphosphate (ATP) concentration: a switch in the decision be-
tween apoptosis and necrosis. J. Exp. Med. 185:1481–1486.
Li, H., and J. Yuan. 1999. Deciphering the pathways of life and death. Curr. Opin.
Cell Biol. 11:261–266.
Los, M., S. Wesselborg, and K. Schulze-Osthoff. 1999. The role of caspases in de-
velopment, immunity, and apoptotic signal transduction: lessons from
knockout mice. Immunity. 10:629–639.
Lowy, F.D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520–532.
Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their rela-
tives. Science. 240:705–711.
McDevitt, D., P. Francois, P. Vaudaux, and T.J. Foster. 1994. Molecular charac-
terization of the clumping factor (fibrinogen receptor) of Staphylococcus au-
reus. Mol. Microbiol. 11:237–248.
Menzies, B.E., and I. Kourteva. 1998. Internalization of Staphylococcus aureus by
endothelial cells induces apoptosis. Infect. Immun. 66:5994–5998.
Menzies, B.E., and I. Kourteva. 2000. Staphylococcus aureus alpha-toxin induces
apoptosis in endothelial cells. FEMS Immunol. Med. Microbiol. 29:39–45.
Müller, A., D. Gunther, V. Brinkmann, R. Hurwitz, T.F. Meyer, and T. Rudel.
2000. Targeting of the pro-apoptotic VDAC-like porin (PorB) of Neisseria
gonorrhoeae to mitochondria of infected cells. EMBO J. 19:5332–5343.
Nicoletti I., G. Migliorati, M.C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A
rapid and simple method for measuring thymocyte apoptosis by propidium
iodide staining and flow cytometry. J. Immunol. Methods. 139:271–279.
Novick, R.P., H.F. Ross, S.J. Projan, J. Kornblum, B. Kreiswirth, and S. Mog-
hazeh. 1993. Synthesis of staphylococcal virulence factors is controlled by a
regulatory RNA molecule. EMBO J. 12:3967–3975.
Nuzzo, I., M.R. Sanges, A. Folgore, and C.R. Carratelli. 2000. Apoptosis of human
keratinocytes after bacterial invasion. FEMS Immunol. Med. Microbiol. 27:
235–240.
Oberholzer, C., A. Oberholzer, M. Clare-Salzler, and L.L. Moldawer. 2001. Apop-
tosis in sepsis: a new target for therapeutic exploration. FASEB J. 15:879–
892.
O’Reilly, M., J.C.S. Azavedo, S. Kennedy, and T.J. Foster. 1986. Inactivation of
the  -hemolysin gene of Staphylococcus aureus 8325-4 by site-directed mu-
tagenesis and studies on the expression of its hemolysins. Microb. Pathol.
1:125–138.
Palmer, M., R. Jursch, U. Weller, A. Valeva, K. Hilgert, M. Kehoe, and S. Bhakdi.
1993. Staphylococcus aureus  -toxin. Production of functionally intact, site-
specifically modifiable protein by introduction of cysteine at positions 69,
130, and 186. J. Biol. Chem. 268:11959–11962.
Porter, A.G., and R.U. Jänicke. 1999. Emerging roles of caspase-3 in apoptosis.
Cell Death Differ. 6:99–104.
Ruckdeschel, K., S. Harb, A. Roggenkamp, M. Hornef, R. Zumbihl, S. Kohler, J.
Heesemann, and B. Rouot. 1998. Yersinia enterocolitica impairs activation of
transcription factor NF- B: involvement in the induction of programmed
cell death and in the suppression of the macrophage tumor necrosis factor  
production. J. Exp. Med. 187:1069–1079.
Rudi, J., D. Kuck, S. Strand, A. von Herbay, S.M. Mariani, P.H. Krammer, P.R.
Galle, and W. Stremmel. 1998. Involvement of the CD95 (APO-1/Fas) re-
ceptor and ligand system in Helicobacter pylori-induced gastric apoptosis. J.
Clin. Invest. 102:1506–1514.S. aureus  -toxin activates the intrinsic death pathway | Bantel et al. 647
Schleifer, K.H., and U. Fischer. 1982. Description of a new species of the genus
Staphylococcus: Staphylococcus carnosus. Int. J. Syst. Bacteriol. 32:153–156.
Schulze-Osthoff, K., D. Ferrari, M. Los, S. Wesselborg, and M.E. Peter. 1998.
Apoptosis signaling by death receptors. Eur. J. Biochem. 254:439–459.
Sinha, B., P.P. Francois, O. Nüße, M. Foti, O.M. Hartford, P. Vaudaux, T.J. Fos-
ter, D.P. Lew, M. Herrmann, and K.H. Krause. 1999. Fibronectin-binding
protein acts as Staphylococcus aureus invasin via fibronectin bridging to inte-
grin  5 1. Cell Microbiol. 1:101–117.
Song, L., M.R. Hobaugh, C. Shustak, S. Cheley, H. Bayley, and J.E. Gouaux.
1996. Structure of staphylococcal  -hemolysin, a heptameric transmem-
brane pore. Science. 274:1859–1866.
Stroh, C., and K. Schulze-Osthoff. 1998. Death by a thousand cuts: an ever in-
creasing list of caspase substrates. Cell Death Differ. 5:997–1000.
Tucker, K.A., S.S. Reilly, C.S. Leslie, and M.C. Hudson. 2000. Intracellular Staph-
ylococcus aureus induces apoptosis in mouse osteoblasts. FEMS Microbiol.
Lett. 186:151–156.
Valeva, A., M. Palmer, and S. Bhakdi. 1997. Staphylococcal  -toxin: formation of
the heptameric pore is partially cooperative and proceeds through multiple
intermediate stages. Biochemistry. 36:13298–13304.
Warny, M., and C.P. Kelly. 1999. Monocytic cell necrosis is mediated by potas-
sium depletion and caspase-like proteases. Am. J. Physiol. 276:C717–C724.
Weinrauch, Y., and A. Zychlinsky. 1999. The induction of apoptosis by bacterial
pathogens. Annu. Rev. Microbiol. 53:155–187.
Wesselborg, S., I.H. Engels, E. Rossmann, M. Los, and K. Schulze-Osthoff. 1999.
Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the
absence of CD95 receptor/ligand interaction. Blood. 93:3053–3063.
Wesson, C.A., J. Deringer, L.E. Liou, K.W. Bayles, G.A. Bohach, and W.R.
Trumble. 2000. Apoptosis induced by Staphylococcus aureus in epithelial
cells utilizes a mechanism involving caspases 8 and 3. Infect. Immun. 68:
2998–3001.
Yang, J., X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J. Cai, T.I. Peng, D.P. Jones,
and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cyto-
chrome-c from mitochondria blocked. Science. 275:1129–1132.
Zychlinsky, A., M.C. Prevost, and P.J. Sansonetti. 1992. Shigella flexneri induces
apoptosis in infected macrophages. Nature. 358:167–169.648 The Journal of Cell Biology | Volume 155, Number 4, 2001